NCT00859482View on ClinicalTrials.gov

Differential Immune Effects of Natalizumab

CompletedOBSERVATIONAL
Enrollment

27

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Multiple Sclerosis, Relapsing Remitting
All Listed Sponsors
lead

Cantonal Hospital of St. Gallen

OTHER

NCT00859482 - Differential Immune Effects of Natalizumab | Biotech Hunter | Biotech Hunter